Carolyn Anderson

Dr. Anderson is Simón-Ellebracht Professor of Medicinal Chemistry & Professor of Radiology at the University of Missouri. She is formerly Professor of Medicine, Radiology, Pharmacology & Chemical Biology and Bioengineering, the Director of the Molecular Imaging Laboratory in the Department of Radiology, and the Co-Director of the UPCI In Vivo Imaging Facility at University of Pittsburg. Dr. Anderson's research interests include development of novel radiometal tracers for diagnostic imaging and targeted radiotherapy of cancer, pulmonary, and cardiovascular diseases. Dr. Anderson pioneered the development of radiometal-labeled receptor-targeted PET imaging agents, leading the first human study of a 64Cu-labeled somatostatin analog in patients with neuroendocrine tumors. A current focus of her research is in the development of imaging agents for upregulated receptors on immune cells that are involved in inflammation related to lung diseases including tuberculosis, primary tumor growth, and cancer metastasis. Another area of interest in is the development of targeted radionuclide therapy agents for prostate cancer and melanoma. The Anderson Lab develops PET radiotracers for imaging of disease with the ultimate goal of translation into humans.